Technological and scientific innovations are transforming healthcare delivery. The integration of quantum computing, AI, and diverse health data sources from MedTech devices, wearables, and genomics, enables precise diagnostics and the development of life-extending therapies. Real-time population health profiles, ethically constructed from this data, facilitate the identification of disease drivers and the creation of advanced, personalised treatments, building on earlier breakthroughs in gene therapies and immunotherapy. These advancements, along with innovations in pharmacogenomics, nanotechnology, and implantable devices, have significantly increased survival rates for some diseases.1
There are four cross-cutting constraints that could affect the prediction (not having the right skills and talent, funding models, approach to regulation, and data governance in place). The prediction can be realised by turning the constraints into enablers, for example by:
Deloitte’s latest Predictions perspective outlines how the acceleration of innovations in science and technology will change healthcare delivery. Advances in quantum computing, AI, and the availability of data from diverse health data sources such as MedTech devices, wearables, and genomics is rapidly enabling more precise, predictive, and personalised diagnostics and treatments that may extend life and deliver better health outcomes.
This will drive improved insights on population health drivers and personalised treatment options that will significantly increase survival rates for some diseases. Constraints include not having the right skills and talent, accessing funding models, the approach to regulation, and having the appropriate data governance in place.
Australia should focus on attracting the right talent with expertise in clinical pharmacology, computational biology, AI, and regulatory compliance as well as clinicians who possess strong digital skills and a deep understanding of multi-omics and AI-driven treatments. This will require active drivers to attract and retain this talent from abroad as well as creating opportunities for these skills to be developed locally. Aiming to share diagnostics data to the national My Health Record by default is a great starting point to support collaboration and information sharing across the health ecosystem.
We still need to continue to embed robust cybersecurity measures and privacy requirements to support the building of citizen trust in these new areas of innovation.
Reference
Our predictions Series for the Life Sciences and healthcare Industry looks ahead to the year 2030 to help you to see what’s coming and to keep your organisation moving forward.
If you would like to discuss any of the points raised in our predictions, please do contact one of our specialists listed below.
Read other predictions in the Series